Home > Investor Information > Overview
Main contents starts here
Overview
Takeda aims to become a company that grows together with its shareholders and other stakeholders while developing a strong identity as a good corporate citizen. Takeda has committed to strengthening information disclosure activities. Takeda is proactively striving for information disclosure, based on the Company policy targeting management transparency.
IR News
- September 2, 2010
Orexigen® Therapeutics and Takeda Enter into Partnership to Commercialize Contrave® in North America - August 31, 2010
Takeda Announces New Initiative in Cell Culture-Based Influenza Vaccines - August 20, 2010
Approval of Additional Indication of NESINA®: Combination Therapy with Thiazolidinediones for Type 2 Diabetes in Japan - August 20, 2010
Approval of an Additional Indication of “Takepron® Capsules 15” and “Takepron® OD Tablets 15” for Prevention of Recurrence of NSAIDs-Associated Gastric Ulcer/Duodenal Ulcer in Japan - August 5, 2010
AFFYMAX AND TAKEDA ANNOUNCE PRELIMINARY U.S. REGISTRATION STRATEGY FOR INVESTIGATIONAL DRUG, HEMATIDE™/PEGINESATIDE, TO TREAT ANEMIA IN CHRONIC RENAL FAILURE
Latest Financial Results
FY 2010 Q1 Results
( July 30, 2010 )
 |
|
|
-
- →link to Nomura IR's website
Latest Reports
2009 Annual Report
|
|
2009 CSR Databook
|
|
IR Calendar
- February 3, 2010
3rd Quarter of FY2009 financial results announcement & conference call - May 12, 2010
FY2009 financial results announcement - May 13, 2010
Analysts/Institutional investors meeting on results for FY2009 (at the Tokyo Office) - June 3, 2010
Convocation notice of the Ordinary General Meeting of Shareholders - June 25, 2010
Ordinary General Meeting of Shareholders - June 25, 2010
Resolutions notice of the Ordinary General Meeting of Shareholders - June 28, 2010
Commencement date for dividend payment (For the year ended March 31, 2010) - July 30, 2010
1st Quarter of FY2010 financial results announcement & conference call - November, 2010
Annual Report 2010 (For the year ended March 31, 2011) - Early November, 2010
2nd Quarter of FY2010 financial results announcement - Early November, 2010
Media/Analysts/Institutional investors meeting on results for the 2nd Quarter of FY2010 (at the Tokyo Office) - Early December, 2010
Commencement date for payment of interim dividend (For the year ended March 31, 2011)
Note : that the dates shown above are tentative plans and subject to change.
Stock Performance
TSE 9/2 15:00
- Last
- 3,890
- Change
- +35